287 related articles for article (PubMed ID: 23603900)
1. Human papillomavirus predicts the outcome following concomitant chemoradiotherapy in patients with head and neck squamous cell carcinomas.
Duray A; Descamps G; Decaestecker C; Sirtaine N; Gilles A; Khalifé M; Chantrain G; Depuydt CE; Delvenne P; Saussez S
Oncol Rep; 2013 Jul; 30(1):371-6. PubMed ID: 23603900
[TBL] [Abstract][Full Text] [Related]
2. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
[TBL] [Abstract][Full Text] [Related]
3. HPV genotypes and their prognostic significance in head and neck squamous cell carcinomas.
Rautava J; Kuuskoski J; Syrjänen K; Grenman R; Syrjänen S
J Clin Virol; 2012 Feb; 53(2):116-20. PubMed ID: 22177275
[TBL] [Abstract][Full Text] [Related]
4. Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC.
Linge A; Schötz U; Löck S; Lohaus F; von Neubeck C; Gudziol V; Nowak A; Tinhofer I; Budach V; Sak A; Stuschke M; Balermpas P; Rödel C; Bunea H; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Lauber K; Pigorsch S; Combs SE; Mönnich D; Zips D; Baretton GB; Buchholz F; Krause M; Belka C; Baumann M;
Radiother Oncol; 2018 Apr; 127(1):27-35. PubMed ID: 29295747
[TBL] [Abstract][Full Text] [Related]
5. Detection of Human Papilloma Virus and Risk Factors among Patients with Head and Neck Squamous Cell Carcinoma Attending a Tertiary Referral Centre in South India.
Bandhary SK; Shetty V; Saldanha M; Gatti P; Devegowda D; R PS; Shetty AK
Asian Pac J Cancer Prev; 2018 May; 19(5):1325-1330. PubMed ID: 29802694
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V
Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236
[TBL] [Abstract][Full Text] [Related]
7. Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapy.
Pogorzelski M; Ting S; Gauler TC; Breitenbuecher F; Vossebein I; Hoffarth S; Markowetz J; Lang S; Bergmann C; Brandau S; Jawad JA; Schmid KW; Schuler M; Kasper S
Cell Death Dis; 2014 Feb; 5(2):e1091. PubMed ID: 24577089
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus infection on initiating synchronous esophageal neoplasia in patients with head and neck cancer.
Wang WL; Wang YC; Chang CY; Lo JL; Kuo YH; Hwang TZ; Wang CC; Mo LR; Lin JT; Lee CT
Laryngoscope; 2016 May; 126(5):1097-102. PubMed ID: 27107411
[TBL] [Abstract][Full Text] [Related]
9. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus and head and neck squamous cell carcinomas in the South-East of France: prevalence, viral expression, and prognostic implications.
Gavid M; Pillet S; Pozzetto B; Oriol M; Dumollard JM; Timoshenko AP; Martin C; Prades JM
Acta Otolaryngol; 2013 May; 133(5):538-43. PubMed ID: 23350597
[TBL] [Abstract][Full Text] [Related]
11. Computed Tomography Radiomics Predicts HPV Status and Local Tumor Control After Definitive Radiochemotherapy in Head and Neck Squamous Cell Carcinoma.
Bogowicz M; Riesterer O; Ikenberg K; Stieb S; Moch H; Studer G; Guckenberger M; Tanadini-Lang S
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):921-928. PubMed ID: 28807534
[TBL] [Abstract][Full Text] [Related]
12. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinoma.
Duray A; Descamps G; Decaestecker C; Remmelink M; Sirtaine N; Lechien J; Ernoux-Neufcoeur P; Bletard N; Somja J; Depuydt CE; Delvenne P; Saussez S
Laryngoscope; 2012 Jul; 122(7):1558-65. PubMed ID: 22532307
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous human papillomavirus in head and neck squamous cell carcinomas.
Lindel K; Helmke B; Simon C; Weber KJ; Debus J; de Villiers EM
Cancer Invest; 2009 Aug; 27(7):781-7. PubMed ID: 19513898
[TBL] [Abstract][Full Text] [Related]
15. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J
Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus and head and neck squamous cell carcinoma in a UK population: Is there an association?
Al-Dabbagh R; Al-Hazmi N; Alhazzazi TY; Barrett AW; Speight PM
Indian J Cancer; 2022; 59(1):65-72. PubMed ID: 33753602
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of human papillomavirus in laryngeal and hypopharyngeal squamous cell carcinomas in northern Spain.
Rodrigo JP; Hermsen MA; Fresno MF; Brakenhoff RH; García-Velasco F; Snijders PJ; Heideman DA; García-Pedrero JM
Cancer Epidemiol; 2015 Feb; 39(1):37-41. PubMed ID: 25468644
[TBL] [Abstract][Full Text] [Related]
18. Performance of the Roche cobas 4800 high-risk human papillomavirus test in cytologic preparations of squamous cell carcinoma of the head and neck.
Kerr DA; Pitman MB; Sweeney B; Arpin RN; Wilbur DC; Faquin WC
Cancer Cytopathol; 2014 Mar; 122(3):167-74. PubMed ID: 24259368
[TBL] [Abstract][Full Text] [Related]
19. Viral load, physical status, and E6/E7 mRNA expression of human papillomavirus in head and neck squamous cell carcinoma.
Deng Z; Hasegawa M; Kiyuna A; Matayoshi S; Uehara T; Agena S; Yamashita Y; Ogawa K; Maeda H; Suzuki M
Head Neck; 2013 Jun; 35(6):800-8. PubMed ID: 22791649
[TBL] [Abstract][Full Text] [Related]
20. Definitive radiation therapy without chemotherapy for human papillomavirus-positive head and neck cancer.
Chen AM; Zahra T; Daly ME; Farwell DG; Luu Q; Gandour-Edwards R; Vaughan AT
Head Neck; 2013 Nov; 35(11):1652-6. PubMed ID: 23335285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
